Cerespectus Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Cerespectus General Information

Description

Developer of a catheter delivery system designed to allow precise gene therapy targeting of central nervous system disorders. The company features a multi-lumen catheter equipped with a camera system for real-time visualization of brain and spine anatomy, leveraging techniques from interventional neuroradiology and endovascular neurosurgery to facilitate accurate catheter placement by physicians, enabling professionals to enhance the efficacy of neurological treatments.

Contact Information

Website
www.cerespectus.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3401 Grays Ferry Avenue
  • Building 450, Suite 1037
  • Philadelphia, PA 19146
  • United States
Primary Industry
Drug Delivery
Corporate Office
  • 3401 Grays Ferry Avenue
  • Building 450, Suite 1037
  • Philadelphia, PA 19146
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerespectus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Product Development
4. Accelerator/Incubator 19-Mar-2025 Completed Product Development
3. Accelerator/Incubator 01-Aug-2024 Completed Product Development
2. Accelerator/Incubator 26-Jul-2024 Completed Product Development
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Cerespectus’s complete valuation and funding history, request access »

Cerespectus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerespectus Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Science Center Accelerator/Incubator
National Science Foundation Innovation Corps Program Accelerator/Incubator
Penn Health-Tech Accelerator/Incubator Minority
Penn Center for Innovation Accelerator/Incubator
HiveBio Accelerator/Incubator
To view Cerespectus’s complete investors history, request access »

Ready to get started?

Request a free trial

Cerespectus FAQs

  • When was Cerespectus founded?

    Cerespectus was founded in 2018.

  • Where is Cerespectus headquartered?

    Cerespectus is headquartered in Philadelphia, PA.

  • What is the size of Cerespectus?

    Cerespectus has 3 total employees.

  • What industry is Cerespectus in?

    Cerespectus’s primary industry is Drug Delivery.

  • Is Cerespectus a private or public company?

    Cerespectus is a Private company.

  • What is Cerespectus’s current revenue?

    The current revenue for Cerespectus is .

  • Who are Cerespectus’s investors?

    Science Center, National Science Foundation Innovation Corps Program, Penn Health-Tech, Penn Center for Innovation, and HiveBio have invested in Cerespectus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process